BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

LD-2 disclosure · 3rd Quarter - Report

LUMOS DIAGNOSTICS

via BOSE PUBLIC AFFAIRS GROUP

3rd Quarter (July 1 - Sep 30) · 2021Posted Oct 19, 2021Filing document ↗LDA record ↗

Income$10Kfee reported

Client

Name: LUMOS DIAGNOSTICS
Description: Point of care healthcare solutions company
Location: Florida · United States of America

Registrant

Firm: BOSE PUBLIC AFFAIRS GROUP
Description: Public Affairs Firm
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Health Issues
healthcare issues for COVID-19 diagnostic testing.
LobbyistsVICTOR SMITH
TargetedWhite House Office · Health & Human Services, Dept of (HHS) · Food & Drug Administration (FDA)

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

LUMOS DIAGNOSTICS — Lobbying — Receipts Report